Table 1.

HGF Levels (ng/ml) in Serum, Peritoneal Fluid, and Supernatant of PBMCs and PtMCs

	Non-CAPD	CAPD	CAPDP
Serum	0.94 ± 0.12	1.10 ± 0.15	2.90 ± 0.12*
Peritoneal fluid	0.13 ± 0.04	0.25 ± 0.06	2.5 ± 0.90*
PBMC supernatant	0.12 ± 0.05	0.12 ± 0.05	0.40 ± 0.08*
PtMC supernatant	0.29 ± 0.04	0.40 ± 0.06	0.92 ± 0.06*

Non-CAPD are samples from controls not treated with peritoneal dialysis (normal volunteers for serum and PBMC supernatant; uremic patients on conservative treatment for peritoneal fluid and PtMC supernatant; see Methods for details); CAPD are samples from patients on peritoneal dialysis without peritonitis; CAPDP are samples from patients on peritoneal dialysis with peritonitis. Numbers are means ± SD. *P < 0.001 versus CAPD and non-CAPD.